Celldex Therapeutics, Inc. (CLDX)

NASDAQ

$27.08

-$0.43 (1.56%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$26.82$27.90

Open $27.90

52 Week Range

$14.40$30.50

Previous Close $27.51

Market Cap1.80B

Volume670.89K

Avg Volume924.06K

P/E (TTM)-9.01

EPS (TTM)$-3.01

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$21.00

Based on 3 analysts (last year)

High Target

$21.00

Low Target

$21.00

Potential downside of -22.45%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$23.00

2 analysts

Last Year

$30.67

3 analysts

All Time

$45.50

8 analysts

Analyst Consensus

Current Consensus

Buy

Based on 18 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity4/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share3/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 11, 2025	Unknown	Barclays	$21.00	$22.67	-7.37%
Oct 13, 2025	Unknown	Barclays	$25.00	$26.77	-6.61%
Mar 20, 2025	Unknown	Morgan Stanley	$46.00	$19.88	+131.39%
Oct 29, 2024	Joseph Pantginis	H.C. Wainwright	$80.00	$27.11

Recent Analyst Actions


Nov 11, 2025	Maintained	Barclays	Underweight	Underweight
Sep 17, 2025	Maintained	Canaccord Genuity	Buy	Buy
Aug 20, 2025	Maintained	Wells Fargo	Overweight	Overweight
Aug 20, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Aug 20, 2025	Maintained	Citigroup	Buy	Buy

Showing 1 to 5 of 148 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$21.00

Based on 3 analysts (last year)

High Target

$21.00

Low Target

$21.00

Potential downside of -22.45%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$23.00

2 analysts

Last Year

$30.67

3 analysts

All Time

$45.50

8 analysts

Analyst Consensus

Current Consensus

Buy

Based on 18 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity4/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share3/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 11, 2025	Unknown	Barclays	$21.00	$22.67	-7.37%
Oct 13, 2025	Unknown	Barclays	$25.00	$26.77	-6.61%
Mar 20, 2025	Unknown	Morgan Stanley	$46.00	$19.88	+131.39%
Oct 29, 2024	Joseph Pantginis	H.C. Wainwright	$80.00	$27.11

Recent Analyst Actions


Nov 11, 2025	Maintained	Barclays	Underweight	Underweight
Sep 17, 2025	Maintained	Canaccord Genuity	Buy	Buy
Aug 20, 2025	Maintained	Wells Fargo	Overweight	Overweight
Aug 20, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Aug 20, 2025	Maintained	Citigroup	Buy	Buy

Showing 1 to 5 of 148 entries